Us Dilated Cardiomyopathy Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Dilated Cardiomyopathy Market was valued at USD 3.5 Billion in 2022 and is projected to reach USD 5.7 Billion by 2030, growing at a CAGR of 6.5% from 2024 to 2030.
Dilated Cardiomyopathy (DCM) is a condition characterized by the enlargement and weakening of the heart's chambers, leading to reduced cardiac function. In the United States, the DCM market has experienced significant growth, driven by increasing awareness, advancements in treatment options, and a rising patient population. As of 2023, the U.S. DCM market was valued at approximately USD 329.4 million. This growth is attributed to heightened awareness of the disease and the introduction of emerging therapies. Among the currently used therapies, Renin-angiotensin system inhibitors (RASi), including ACE inhibitors and ARBs, held the majority market share, generating around USD 94.1 million in 2023. The only FDA-approved product for DCM, Amgen’s CORLANOR (ivabradine), contributed an additional USD 90.3 million in revenue during the same year. citeturn0search0 The late-stage pipeline for DCM treatments is relatively limited. However, emerging therapies like Bristol-Myers Squibb's danicamtiv (MYK-491), a selective cardiac myosin activator, are anticipated to enter the U.S. market by 2027. This therapy aims to improve left ventricular volume and function while maintaining relaxation, potentially altering the market dynamics upon its introduction. citeturn0search0 In terms of market access and reimbursement, the high costs associated with DCM treatments can impact patient affordability and access. Programs such as the CORLANOR Patient Support Program, launched by the Amgen Safety Net Foundation, offer qualifying patients free access to Amgen medications, addressing some of these challenges. citeturn0search3 Overall, the U.S. DCM market is poised for growth, driven by increased awareness, the introduction of new therapies, and supportive reimbursement programs. These factors collectively contribute to improved patient outcomes and a more robust healthcare landscape for those affected by DCM.
Get an In-Depth Research Analysis of the Global Dilated Cardiomyopathy Market Size And Forecast [2025-2032]
Zensun
Capricor Therapeutics
Vericel
t2cure GmbH
MyoKardia
Kasiak Research
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Dilated Cardiomyopathy Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Dilated Cardiomyopathy Market
Ischemic Dilated Cardiomyopathy
Non-Ischemic Dilated Cardiomyopathy
Medication
Surgical Procedures
Devices
Pediatric Patients
Adult Patients
Elderly Patients
Blood Tests
Imaging Techniques
Electrophysiological Studies
Hospitals
Cardiology Clinics
Research Laboratories
Home Healthcare Settings
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Dilated Cardiomyopathy Market Research Analysis
1. Introduction of the Global Dilated Cardiomyopathy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Dilated Cardiomyopathy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Dilated Cardiomyopathy Market, By Type
6. Global Dilated Cardiomyopathy Market, By Application
7. Global Dilated Cardiomyopathy Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Dilated Cardiomyopathy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/